Filtros de búsqueda

Lista de obras de Martin J van den Bent

1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.

artículo científico publicado en 1997

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

artículo científico publicado en 2006

A 40-year-old woman with a progressive periventricular white matter lesion

artículo científico publicado en 2008

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma

scientific article published on 27 November 2019

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

artículo científico publicado en 2011

A novel tool to analyze MRI recurrence patterns in glioblastoma

scientific article published on 31 July 2008

A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).

artículo científico publicado en 2012

A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.

artículo científico publicado en 1997

A solitary spinal cord toxoplasma lesion after peripheral stem-cell transplantation

artículo científico publicado en 2001

A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab ⬇️

artículo científico publicado en 2016

Abstracts of the 10th Congress of the European Association of NeuroOncology. Marseille, France. September 6-9, 2012

artículo científico publicado en 2012

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer.

artículo científico publicado en 2003

Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time

artículo científico publicado en 2011

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

artículo científico publicado en 2012

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

artículo científico publicado en 2006

Adjuvant treatment of high grade gliomas.

artículo científico publicado en 2006

Advances in the biology and treatment of oligodendrogliomas.

artículo científico publicado en 2004

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

artículo científico publicado en 2010

An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes

artículo científico publicado en 2006

Anaplastic oligodendroglial tumors.

artículo científico

Anaplastic oligodendroglioma and oligoastrocytoma.

artículo científico publicado en 2007

Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells

artículo científico publicado en 2017

Are we done with dose-intense temozolomide in recurrent glioblastoma?

artículo científico publicado en 2014

Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: A systematic review

artículo científico

Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative study.

artículo científico publicado en 2005

B and T cell imbalances in CSF of patients with Hu-antibody associated PNS.

artículo científico publicado en 2008

Barriers to Accrual and Enrollment in Brain Tumor Trials

artículo científico publicado en 2019

Bevacizumab alone or in combination with chemotherapy in glioblastomas?--authors' reply

artículo científico publicado en 2014

Bevacizumab and recurrent malignant gliomas: a European perspective

artículo científico publicado en 2010

Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial

scientific article published on 13 August 2018

CLIN-NEURO/MEDICAL ONCOLOGY

Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.

artículo científico publicado en 2003

Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: two-year follow-up results.

artículo científico publicado en 2007

Cerebral venous and sinus thrombosis with cerebrospinal fluid circulation block after the first methotrexate administration by lumbar puncture

artículo científico publicado en 2002

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

artículo científico publicado en 2013

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.

artículo científico

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.

artículo científico publicado en 2015

Chemotherapy for low-grade glioma: when, for whom, which regimen?

artículo científico

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

artículo científico publicado en 2003

Chromosome 1p loss evaluation in anaplastic oligodendrogliomas

article

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

artículo científico publicado en 2014

Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule.

artículo científico publicado en 1994

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

article

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

artículo científico publicado en 2018

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

artículo científico publicado en 2018

Clinical trial end points for high-grade glioma: the evolving landscape.

scientific article published on 09 February 2011

Cognitive functioning and health-related quality of life in patients with newly diagnosed primary CNS lymphoma: a systematic review

artículo científico publicado en 2018

Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.

artículo científico publicado en 2002

Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.

artículo científico publicado en 2009

Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial

artículo científico publicado en 2017

Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma

scientific article published on 22 February 2019

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

artículo científico publicado en 2015

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group

artículo científico publicado en 2018

Current treatment of low grade gliomas

artículo científico publicado en 2012

DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells.

artículo científico publicado en 2014

Deafness, sensory neuropathy, and ovarian dysgenesis: a new syndrome or a broader spectrum of Perrault syndrome?

artículo científico publicado en 1994

Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing: 1p/19q Co-Deletion Analysis of Gliomas.

artículo científico publicado en 2016

Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.

artículo científico publicado en 2005

Diffuse Infiltrating Oligodendroglioma and Astrocytoma.

artículo científico publicado en 2017

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.

artículo científico publicado en 2017

Does early resection of presumed low-grade glioma improve survival? A clinical perspective.

artículo científico publicado en 2017

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

artículo científico publicado en 2012

Dose-dense cisplatin/paclitaxel. a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer.

artículo científico publicado en 2002

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.

artículo científico publicado en 2014

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

scientific article published on 08 December 2020

EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab ⬇️

artículo científico publicado el 7 de diciembre de 2010

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

artículo científico publicado en 2012

Effect of an ACTH(4–9) analogue on cisplatin neuropathy of longstanding duration: a phase II study ⬇️

artículo científico publicado el 1 de mayo de 1995

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.

artículo científico publicado en 2017

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.

artículo científico publicado en 2017

Efficacy of intrathecal chemotherapy in patients with central nervous system involvement of hematological malignancies: a retrospective analysis.

artículo científico publicado en 2018

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria

artículo científico publicado en 2009

Erratum to: MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and

article

Erythropoietin induced visual hallucinations after bone marrow transplantation

artículo científico publicado en 1999

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.

artículo científico publicado en 2017

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.

artículo científico publicado en 2003

Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials

artículo científico publicado en 2015

Evidence-based management of adult patients with diffuse glioma - Authors' reply

artículo científico publicado en 2017

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.

artículo científico publicado en 2018

Facing the future of brain tumor clinical research

artículo científico publicado en 2014

Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence.

artículo científico publicado en 2017

Federated learning enables big data for rare cancer boundary detection

Flow cytometry shows added value in diagnosing lymphoma in brain biopsies.

artículo científico publicado en 2018

For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group.

artículo científico publicado en 1998

Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.

artículo científico publicado en 2008

Gene expression profiles associated with treatment response in oligodendrogliomas.

artículo científico publicado en 2005

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material.

artículo científico publicado en 2011

Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities

artículo científico publicado en 2016

Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH)

artículo científico publicado en 1999

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

artículo científico publicado en 2010

Grade II and III Oligodendroglioma and Astrocytoma

artículo científico publicado en 2018

Hemangioblastomatosis in a patient with von Hippel-Lindau disease

artículo científico publicado en 2007

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

artículo científico publicado en 2003

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

artículo científico publicado en 2014

Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes

artículo científico publicado en 2010

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

artículo científico publicado en 2010

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

artículo científico publicado en 2016

Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration

artículo científico publicado en 2012

Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays.

artículo científico publicado en 2007

Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.

artículo científico publicado en 2006

Imaging Correlates of Adult Glioma Genotypes.

artículo científico publicado en 2017

Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment.

artículo científico publicado en 2008

Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.

artículo científico publicado en 2017

Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors.

artículo científico publicado en 2000

Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.

artículo científico publicado en 2002

Increased rCBV in status epilepticus.

artículo científico publicado en 2012

Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene.

artículo científico publicado en 2010

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

artículo científico publicado en 2017

Interlaboratory comparison of IDH mutation detection.

artículo científico

Interview: Improving outcome for brain tumor patients.

artículo científico publicado en 2012

Intracranial granulocytic sarcoma (chloroma) may mimic a subdural hematoma

artículo científico publicado en 2005

Intratumoral distribution of 1p loss in oligodendroglial tumors.

artículo científico publicado en 2007

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

artículo científico publicado en 2009

Joint modeling of longitudinal health-related quality of life data and survival

artículo científico publicado en 2014

Leptomeningeal metastases: a RANO proposal for response criteria.

artículo científico publicado en 2016

Leptomeningeal metastasis after surgical resection of brain metastases

artículo científico publicado en 1999

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

artículo científico publicado en 2014

Lomustine and Bevacizumab in Progressive Glioblastoma

artículo científico publicado en 2017

Low-grade and anaplastic oligodendroglioma.

artículo científico publicado en 2016

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.

artículo científico publicado en 2010

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

artículo científico publicado en 2009

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

artículo científico publicado en 2009

MGMT testing--the challenges for biomarker-based glioma treatment

artículo científico publicado en 2014

Management of metastatic (parenchymal, leptomeningeal, and epidural) lesions.

artículo científico publicado en 2004

Memory in low-grade glioma patients treated with radiotherapy or Temozolomide. A correlative analysis of EORTC study 22033-26033

scientific article published on 01 November 2020

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.

artículo científico publicado en 2011

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

artículo científico publicado en 2009

Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification

artículo científico publicado en 2017

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.

artículo científico publicado en 2015

Molecular diagnostics of gliomas: the clinical perspective

artículo científico publicado en 2010

Molecular targeted therapies and chemotherapy in malignant gliomas.

artículo científico publicado en 2007

NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101

Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma

scientific article published on 03 November 2018

Neuro-oncology: The many challenges of treating elderly glioblastoma patients.

artículo científico publicado en 2015

Neurocognitive functions and quality of life in haematological patients receiving haematopoietic stem cell grafts: a one-year follow-up pilot study.

artículo científico publicado en 2006

Neurological adverse effects caused by cytotoxic and targeted therapies.

artículo científico publicado en 2009

Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration.

artículo científico publicado en 1995

New perspectives for the diagnosis and treatment of oligodendroglioma.

artículo científico publicado en 2001

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

artículo científico publicado en 2012

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials

scientific article published on 18 September 2013

No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.

artículo científico publicado en 2009

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

artículo científico publicado en 2007

Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial

artículo científico publicado en 2020

Novel methods to diagnose leptomeningeal metastases in breast cancer

scientific article published on 01 March 2019

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.

artículo científico publicado en 2018

OMICS AND PROGNSTIC MARKERS

article

Oligodendroglioma: pathology, molecular mechanisms and markers

artículo científico publicado en 2015

Oligodendrogliomas: molecular biology and treatment.

artículo científico publicado en 2009

On high-risk, low-grade glioma: What distinguishes high from low?

scientific article published on 04 December 2018

Optimal management of elderly patients with glioblastoma

artículo científico publicado en 2012

Optimal role of temozolomide in the treatment of malignant gliomas.

artículo científico publicado en 2005

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

scientific article published on 24 January 2020

PCV chemotherapy for recurrent glioblastoma multiforme.

artículo científico publicado en 2001

PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients

artículo científico publicado en 2015

Paclitaxel (Taxol) induces cumulative mild neurotoxicity

artículo científico publicado en 1994

Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

artículo científico publicado en 2003

Peri-ictal pseudoprogression in patients with brain tumor

artículo científico publicado en 2011

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin

artículo científico publicado en 1997

Peripheral neurotoxicity induced by docetaxel.

artículo científico publicado en 1996

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice

artículo científico publicado en 2012

Phase 2 trial design in neuro-oncology revisited: a report from the RANO group

artículo científico publicado en 2012

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).

artículo científico publicado en 2016

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

artículo científico publicado en 2003

Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.

artículo científico publicado en 1999

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

artículo científico publicado en 1998

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma

artículo científico publicado en 2013

Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma

artículo científico publicado en 2010

Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.

artículo científico publicado en 2014

Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet?

artículo científico publicado en 2018

Preface

Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis

artículo científico publicado en 2010

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

artículo científico publicado en 2002

Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.

artículo científico publicado en 2018

Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB t

artículo científico publicado en 2015

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

artículo científico publicado en 2007

Prolonged remission of primary central nervous system lymphoma after discontinuation of steroid therapy

artículo científico publicado el 1 de julio de 1992

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

artículo científico publicado en 2011

Pros and cons of current brain tumor imaging

artículo científico publicado en 2014

Pseudoprogression and pseudoresponse in the treatment of gliomas

artículo científico publicado en 2009

Pseudoprogression of brain tumors.

artículo científico publicado en 2018

Quantification of leptomeningeal metastases from solid tumors remains a challenging issue

artículo científico publicado en 2020

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

artículo científico publicado en 2006

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

artículo científico publicado en 2005

Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.

artículo científico publicado en 2018

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

artículo científico publicado en 2009

Recent developments in the use of chemotherapy in brain tumours.

artículo científico publicado en 2006

Reply to M.C. Chamberlain.

artículo científico publicado en 2014

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

artículo científico publicado en 2005

Resolution of EBV(+) CNS lymphoma with appearance of CSF EBV-specific T cells

artículo científico publicado en 2005

Response Assessment in Neuro-Oncology Clinical Trials.

artículo científico publicado en 2017

Response assessment criteria for brain metastases: proposal from the RANO group.

artículo científico publicado en 2015

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

artículo científico publicado en 2011

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

artículo científico publicado en 1998

Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.

artículo científico publicado en 2019

Safety, Pharmacokinetics and Antitumor Response of Depatuxizumab Mafodotin as Monotherapy or in Combination with Temozolomide in Patients with Glioblastoma.

artículo científico publicado en 2017

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.

artículo científico publicado en 2004

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

artículo científico publicado en 2003

Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.

artículo científico publicado en 2016

Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.

artículo científico

Severe amnesia due to HHV-6 encephalitis after allogenic stem cell transplantation

scientific article published on 01 January 2005

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

artículo científico publicado en 2014

Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy

artículo científico publicado en 2002

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

artículo científico publicado en 2016

The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma.

artículo científico publicado en 2010

The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.

artículo científico publicado en 2018

The European Organisation for Research and Treatment of Cancer strategy for new drug development in brain tumors.

artículo científico publicado en 2003

The T2-FLAIR Mismatch Sign as an Imaging Marker for Non-Enhancing IDH-mutant, 1p/19q-intact Lower Grade Glioma: A Validation Study.

artículo científico publicado en 2018

The accumulation of topotecan in 9L glioma and in brain parenchyma with and without dexamethasone administration.

artículo científico publicado en 1999

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

scientific article published on 13 June 2019

The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.

artículo científico publicado en 1998

The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trial

artículo científico publicado en 2015

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.

artículo científico publicado en 2017

The management of cerebral metastasis from germ cell cancer; walking the tightrope.

artículo científico publicado en 2008

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group s

artículo científico publicado en 2007

The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study

artículo científico publicado en 2004

The role of chemotherapy in brain metastases.

artículo científico publicado en 2003

Timing of radiotherapy in newly diagnosed glioblastoma: no need to rush?

scientific article published on 01 June 2018

Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.

artículo científico publicado en 2014

Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study

artículo científico publicado en 2016

Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report.

artículo científico publicado en 2017

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

artículo científico publicado en 2003

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda